Sebastien Ladet - Affluent Medical Chief Officer
| AFME Stock | 1.60 0.02 1.27% |
Executive
Sebastien Ladet is Chief Officer of Affluent Medical SAS
| Phone | 33 4 42 95 12 20 |
| Web | https://www.affluentmedical.com |
Affluent Medical Management Efficiency
The company has return on total asset (ROA) of (0.1162) % which means that it has lost $0.1162 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3551) %, meaning that it generated substantial loss on money invested by shareholders. Affluent Medical's management efficiency ratios could be used to measure how well Affluent Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | EXECUTIVE Age | ||
| Steve Gibson | Novacyt | N/A | |
| Wendy Karban | Novacyt | N/A | |
| Thierry Paper | Biosynex | N/A | |
Management Performance
| Return On Equity | -0.36 | |||
| Return On Asset | -0.12 |
Affluent Medical SAS Leadership Team
Elected by the shareholders, the Affluent Medical's board of directors comprises two types of representatives: Affluent Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Affluent. The board's role is to monitor Affluent Medical's management team and ensure that shareholders' interests are well served. Affluent Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Affluent Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sebastien Ladet, Chief Officer | ||
| Olivier Pierron, Deputy Officer | ||
| Michel Finance, CEO Chairman | ||
| Pr MD, Medical Director | ||
| Jerome Geoffroy, Chief Officer |
Affluent Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Affluent Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.36 | |||
| Return On Asset | -0.12 | |||
| Operating Margin | (8.42) % | |||
| Current Valuation | 50.42 M | |||
| Shares Outstanding | 20.6 M | |||
| Shares Owned By Insiders | 3.35 % | |||
| Shares Owned By Institutions | 65.00 % | |||
| Price To Book | 0.99 X | |||
| Price To Sales | 22.19 X | |||
| Gross Profit | (1.29 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Affluent Stock
Affluent Medical financial ratios help investors to determine whether Affluent Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Affluent with respect to the benefits of owning Affluent Medical security.